Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psilocybin
CRO
Compass, Hackensack Meridian ink research deal for psilocybin
Compass Pathways inked a research collaboration deal with Hackensack Meridian Health for its investigational COMP360 psilocybin treatment.
Joseph Keenan
Jan 17, 2024 10:53am
Compass shows safety in first psilocybin trial for PTSD
Dec 20, 2023 7:26am
Investors unenthused by Cybin's latest ph. 2 depression data
Nov 30, 2023 9:25am
Psychedelics and the next frontier of mental healthcare
Nov 10, 2023 6:00am
Data on psilocybin in anorexia point Compass to new opportunity
May 3, 2022 8:33am
Relieving depression with LSD-like drugs without hallucinations
Jan 31, 2022 3:30pm